History
  • No items yet
midpage
Aetna, Inc. v. Pfizer, Inc.
712 F.3d 51
1st Cir.
2013
Read the full case

Background

  • Aetna appealed a district court summary judgment that favored Pfizer and against Aetna on RICO and PIFS claims related to Neurontin off-label marketing.
  • The coordinated MDL case alleged fraudulent marketing and resulting harms under RICO and Pennsylvania Insurance Fraud Statute (PIFS).
  • The district court dismissed Guardian and Aetna's claims, including Aetna's PIFS claim, and granted summary judgment as to Aetna’s RICO claim, prompting this appeal.
  • The appellate court previously found evidence of causation and damages sufficient to survive summary judgment in Kaiser and reversed/ remanded in related matters, guiding the present analysis.
  • Aetna proffered aggregate statistical evidence plus circumstantial proof linking Pfizer’s marketing to increased off-label Neurontin prescriptions paid by Aetna; Pfizer argued lack of causation proof and over-reliance on aggregate data.
  • The court reverses the district court on Aetna’s RICO claim and vacates the PIFS ruling, remanding for further proceedings.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Whether aggregate evidence supports but-for causation for RICO. Aetna evidence shows Pfizer’s fraud increased off-label prescriptions paid by Aetna. Pfizer contends aggregate proof insufficient to prove but-for causation. Survives summary judgment; aggregate and circumstantial evidence support but-for causation.
Whether proximate causation is established for private RICO claim. Aggregate evidence plus Rosenthal’s analysis shows causation from fraud to Aetna’s payments. Lack of direct reliance on misrepresentations undermines causation. Sufficient proximate causation; jury could find foreseeability and injury.
Whether Aetna showed economic injury to support RICO claim. Evidence of ineffectiveness and alternative theories show economic injury. Economic injury disputed; dependence on aggregate data is insufficient. Evidence supports economic injury; jury could determine damages.
Whether the Pennsylvania Insurance Fraud Statute claim should be entertained given RICO ruling. PIFS claim should proceed if RICO liability is found. PIFS issue remains separate and unresolved. Vacated as to PIFS; remand for further consideration consistent with ruling.

Key Cases Cited

  • Holmes v. S. Protection Sec. Corp., 503 U.S. 258 (1992) (proximate causation and the Holmes tests favoring liability under civil fraud schemes)
  • Bridge v. Phoenix Bond & Indem. Co., 128 S. Ct. 2131 (2008) (agency-like causation and reliance principles in private RICO)
  • BCS Servs., Inc. v. Heartwood 88, LLC, 637 F.3d 750 (7th Cir. 2011) (damages at the damages phase have relaxed proof requirements)
  • Rockwood v. SKF USA Inc., 687 F.3d 1 (1st Cir. 2012) (standard for reversing summary judgment and evaluating genuine issues of material fact)
Read the full case

Case Details

Case Name: Aetna, Inc. v. Pfizer, Inc.
Court Name: Court of Appeals for the First Circuit
Date Published: Apr 3, 2013
Citation: 712 F.3d 51
Docket Number: 11-1595
Court Abbreviation: 1st Cir.